Literature DB >> 25463117

Effective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injury.

Tunay Şentürk1, Sinan Çavun2, Berrin Avcı3, Aysun Yermezler3, Zehra Serdar4, Vahide Savcı2.   

Abstract

OBJECTIVE: Apoptosis is the early and predominant form of cell death in infarcted myocardia. The aim of the study was to investigate the effects of trimetazidine (TMZ) and N-acetylcysteine (NAC), used alone or in combination, on oxidative stress, infarct size, and ischemia-reperfusion (IR)-induced cardiomyocyte apoptosis in a rat model of myocardial IR. METHODS AND
RESULTS: Myocardial IR was established by ligating an area under the left main coronary artery for 30 min followed by 3 h of reperfusion. Saline (1 ml/kg), NAC (50, 150 mg/kg), or TMZ (3, 5 mg/kg) was intravenously injected during the middle of the ischemic period. At the end of the reperfusion, blood samples were collected from the animals to measure serum M30 and M65 levels, which are markers of cell death, the S100b level, which is a marker of inflammation, and the malondialdehyde (MDA) level, which is a marker of oxidative stress. The infarct size was evaluated as the ratio of the infarct area to the risk area. Apoptotic activation was assessed by caspase-3 immunostaining and a TUNEL assay. TMZ and NAC, either alone or in combination, significantly reduced serum MDA levels, infarct area and apoptotic activity compared to those observed in saline group. Interestingly, the infarct area was more smaller in TMZ (3 and 5 mg/kg) injected groups (9.72 ± 1.3% and 9.96 ± 2.3%) than those observed in NAC (50 and 150 mg/kg) (16.1 ± 2.5% and 19.1 ± 2.14%) or TMZ (5 mg/kg)- NAC (150 mg/kg) combination groups (16.9 ± 1.6%). However, the apoptotic activity was reduced more significantly in the combination of TMZ (5 mg/kg)-NAC (50 mg/kg) compared to TMZ-only group. Neither TMZ or NAC treatments nor the combination of the drugs significantly affected serum M30, M65 and S100B levels.
CONCLUSION: Intravenous NAC and TMZ administration decreased oxidative stress, infarct area and apoptotic activity in a rat model of IR. Although the combination treatment was more effective in reducing the apoptotic activity than either treatment groups alone, TMZ treatment was more successful in reducing the infarct area than NAC or combination treatments. Present results suggest that, in addition to mechanical attempts to secure myocardial reperfusion, the use of TMZ and NAC may help to reduce IR injury.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; M30/M65; Myocardium; N-acetylcysteine; Oxidative stress; Reperfusion injury; Trimetazidine

Mesh:

Substances:

Year:  2014        PMID: 25463117     DOI: 10.1016/j.atherosclerosis.2014.10.091

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Soluble TNF-related apoptosis induced ligand (sTRAIL) is augmented by Post-Conditioning and correlates to infarct size and left ventricle dysfunction in STEMI patients: a substudy from a randomized clinical trial.

Authors:  André Luz; Mário Santos; Rui Magalhães; José Carlos Oliveira; Ana Pacheco; João Silveira; Sofia Cabral; Severo Torres; Adelino F Leite-Moreira; Henrique Carvalho
Journal:  Heart Vessels       Date:  2016-05-26       Impact factor: 2.037

2.  Nucleostemin exerts anti-apoptotic function via p53 signaling pathway in cardiomyocytes.

Authors:  Chi Zhang; Jiahai Shi; Long Qian; Chao Zhang; Kunpeng Wu; Chen Yang; Daliang Yan; Xiang Wu; Xiaojuan Liu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-07-03       Impact factor: 2.416

Review 3.  Mitochondrial Damage in Myocardial Ischemia/Reperfusion Injury and Application of Natural Plant Products.

Authors:  Xin Su; Mingyang Zhou; Yingjian Li; Na An; Fan Yang; Guoxia Zhang; Lianjiang Xu; Hengwen Chen; Hongjin Wu; Yanwei Xing
Journal:  Oxid Med Cell Longev       Date:  2022-05-16       Impact factor: 7.310

4.  Trimetazidine combined with berberine on endothelial function of patients with coronary heart disease combined with primary hypertension.

Authors:  Hui Zhang; Hongyu Niu; Xiangzhi Yuan; Jing Chang; Xiaojuan Wang
Journal:  Exp Ther Med       Date:  2018-06-08       Impact factor: 2.447

5.  Function and Mechanism of Trimetazidine in Myocardial Infarction-Induced Myocardial Energy Metabolism Disorder Through the SIRT1-AMPK Pathway.

Authors:  Xiu-Ying Luo; Ze Zhong; Ai-Guo Chong; Wei-Wei Zhang; Xin-Dong Wu
Journal:  Front Physiol       Date:  2021-06-17       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.